Together, our results uncover a novel mechanism of colchicine in reducing AAA growth by inactivating the METTL14/SOST/WNT/β-catenin pathway and maintaining aortic SMC homeostasis in the aortic wall (Fig. S14). The gene discussed is METTL14; the disease is triple-A syndrome.